Lv31
360 积分 2026-01-13 加入
Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review
4小时前
待确认
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma
11天前
已完结
Platinum accumulation in chemotherapy: toxicity mechanisms, challenges, and mitigation strategies
11天前
已完结
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
15天前
已完结
Incidence of and risk factors for medication-related osteonecrosis of the jaw in women with breast cancer with bone metastasis: a population-based study
15天前
已完结
Risk of Symptomatic Skeletal Events After Discontinuation of Long-term Denosumab in Patients With Bone Metastases: A Retrospective Cohort Study
17天前
已完结
Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation
19天前
已完结
The provision of dental extractions in patients with established or a history of medication-related osteonecrosis of the jaw
19天前
已完结
322P Human epidermal growth factor receptor 2 (HER2)-directed therapies administered after trastuzumab deruxtecan (T-DXd) remain effective in patients (pts) with metastatic breast cancer (mBC): Exploratory analysis from DESTINY-Breast02 and -03
1个月前
已关闭
Mechanisms of resistance to antibody-drug conjugates in breast cancer
1个月前
已完结
皖公网安备34019202002308
